CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Uniqure Biopharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
May 1, 2024Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production1
Dec 28, 2022Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production1
Jun 13, 2018Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production5

Top competitors of Uniqure Biopharma

Top competitors of Uniqure Biopharma based on patent oppositions.